ForSight spinoff acquired by QLT Inc.

Forsight Newco II Inc., a privately-held spinoff of ForSight Labs LLC, has agreed to be acquired by QLT Inc. (QLTI) for $42 million as well as future milestone payments and royalties on net sales of products.

The acquisition includes rights to a proprietary ocular punctual plug drug delivery system, which may have potential as a treatment for glaucoma.

ForSight Labs LLC, an ophthalmic technology incubator backed by Menlo Park investment firm Morgenthaler Ventures, Split Rock Partners and Versant Ventures, spun off its first company, Transcend Medical Inc., in late 2006.

Just Posted

Thirty years after Loma Prieta, is San Francisco ready for the next ‘big one?’

Bay Area residents breathed a sigh of relief this week after a… Continue reading

Mayor sets deadline to empty seismically unsafe jail, but city still lacks a plan to make it happen

On the 30th anniversary of the devastating Loma Prieta earthquake, Mayor London… Continue reading

SF files motion to dismiss NRA’s lawsuit over ‘domestic terrorist’ label

San Francisco filed a motion Thursday to dismiss the lawsuit filed against… Continue reading

With Loftus set to take office, poll shows voters disapprove of last-minute DA appointment

Mayor London Breed made an unpopular decision when she named candidate Suzy… Continue reading

‘My brother in Baltimore’: Pelosi reacts to death of U.S. Rep. Elijah Cummings

U.S. House Speaker and Baltimore native Nancy Pelosi mourned the death of… Continue reading

Most Read